The pharmacy major that runs full-service diagnostic centres in Hyderabad is planning a further capital allocation of Rs 9,000 lakh. “The company expects operating EBITDA break-even in 12 months for the diagnostic centers,” the brokerage noted.Since its listing in December last year, the stock has fallen over 22% from the issue price of Rs 796.
Subscribe To Our Free Newsletter |